BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6317045)

  • 21. Mechanism of action of the platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom.
    Huang TF; Yeh HI; Ouyang C
    Toxicon; 1984; 22(2):243-51. PubMed ID: 6427979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiotoxin from Naja naja atra snake venom: a potentiator of platelet aggregation.
    Teng CM; Jy W; Ouyang C
    Toxicon; 1984; 22(3):463-70. PubMed ID: 6474495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom.
    Huang TF; Chiang HS
    Biochim Biophys Acta; 1994 Feb; 1211(1):61-8. PubMed ID: 8123683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potent platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom.
    Ouyang C; Yeh HI; Huang TF
    Toxicon; 1983; 21(6):797-804. PubMed ID: 6419392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPIb is involved in platelet aggregation induced by mucetin, a snake C-type lectin protein from Chinese habu (Trimeresurus mucrosquamatus) venom.
    Lu Q; Navdaev A; Clemetson JM; Clemetson KJ
    Thromb Haemost; 2004 Jun; 91(6):1168-76. PubMed ID: 15175804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
    Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
    Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venom from southern copperhead snake (Agkistrodon contortrix contortrix). II. A unique phospholipase A2 that induces platelet aggregation.
    Takagi J; Sekiya F; Kasahara K; Inada Y; Saito Y
    Toxicon; 1988; 26(2):199-206. PubMed ID: 3363567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom.
    Huang TF; Ouyang C
    Thromb Res; 1984 Jan; 33(2):125-38. PubMed ID: 6701832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of a new platelet aggregation inhibitor with dissociative effect on ADP-induced platelet aggregation, from the venom of Protobothrops elegans (Sakishima-habu).
    Oyama E; Furudate N; Senuki K; Takahashi H
    Toxicon; 2009 Jun; 53(7-8):706-12. PubMed ID: 19254737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Ouyang CH; Ma YH; Jih HC; Teng CM
    Biochim Biophys Acta; 1985 Jul; 841(1):1-7. PubMed ID: 4016143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of protopine on rabbit platelet function].
    Ma GY; Zhang ZZ; Chen ZH
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
    Huang TF; Wu YJ; Ouyang C
    Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
    Claesson HE; Malmsten C
    Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
    Vallee E; Gougat J; Navarro J; Delahayes JF
    J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bothrops jararaca snake venom: effects on platelet aggregation.
    Zingali RB; Carlini CR; Francischetti IM; GuimarĂ£es JA
    Thromb Res; 1990 May; 58(3):303-16. PubMed ID: 2353342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.